About Careers Internship MedBlog Contact us

Test to Predict HIV Microbicides' Safety Developed

by Rajashri on July 13, 2009 at 9:56 PM
 Test to Predict HIV Microbicides' Safety Developed

A novel test that can help predict whether any microbicide against HIV is safe for human use has been developed by researchers at the Albert Einstein College of Medicine of Yeshiva University.

For years, scientists have been trying to develop a topical vaginal microbicide for preventing transmission of HIV, the virus that causes AIDS.


Several microbicide gels have been assessed in clinical trials after passing laboratory and animal safety tests.

However, all the microbicides were found to be ineffective against HIV, and two of the gels - nonoxynol-9 and cellulose sulfate - actually increased the risk of HIV infection in women.

"Our goal was to develop assays that are predictive of safety before proceeding to clinical trials that typically cost millions of dollars, involve thousands of women, and take many years," said study leader Dr Betsy C. Herold, a professor at Einstein.

While evaluating a microbicide's safety, the researchers look primarily for signs that the chemical inflames cells of the vaginal lining, or epithelium.

Tight junctions between genital tract epithelial cells provide an anatomic barrier, and prevent HIV from reaching submucosal targets.

Microbicides that disrupt the barrier increase the risk for HIV infection.

According to the Dr. Herold, this assay may help in predicting the safety of microbicides.

"Our findings strongly suggest that microbicides can increase the risk of HIV infection through a mechanism other that inflammation - namely, by disrupting the protective epithelial cell barrier," said Herold.

"If confirmed by further study, this assay should be used early on to screen for microbicide safety before advancing a product to clinical trials involving thousands of women," she added.

The study has been published in the Journal of Infectious Diseases.

Source: ANI
Font : A-A+



Recommended Readings

Latest AIDS/HIV News

HIV Vaccine Clinical Trial Initiates in the United States and South Africa
The Phase 1 trial for a preventive HIV vaccine candidate has initiated enrollment in both the United States and South Africa.
Beauty Salon-Driven Initiative Boosts PrEP Awareness in Fight Against AIDS
In the United States, African American women make up only 26% of female PrEP users, yet they account for 57% of new infections among women.
Immune-Evading HIV Protein Complex Solved
Scientists have made a groundbreaking discovery in the fight against HIV/AIDS with the successful resolution of the enigmatic immune-evading HIV protein complex.
Does Gender Influence Comorbidity Rates in HIV-Positive Smokers
Tailored quit-smoking programs are designed to address the risks associated with comorbidity in individuals living with HIV.
Digital Test Measures HIV Viral Load
DNA editing tool CRISPR-Cas13 helps diagnose and signal the presence of HIV antibodies in HIV patients.
View All
This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close
Greetings! How can I assist you?MediBot

Test to Predict HIV Microbicides' Safety Developed Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests